{"data":[{"accessionNo":"0000905148-26-004485","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-14","reportingPerson":"GOODMAN COREY S","reportingCik":null,"personType":"IN,HC","sharesOwned":12927442,"percentOfClass":9.99,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-004485","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-14","reportingPerson":"venBio Global Strategic Fund II L.P.","reportingCik":null,"personType":"PN","sharesOwned":8453038,"percentOfClass":6.5,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-004485","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-14","reportingPerson":"venBio Global Strategic GP II, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":8453038,"percentOfClass":6.5,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-004485","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-14","reportingPerson":"venBio Global Strategic GP II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":8453038,"percentOfClass":6.5,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-004485","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-14","reportingPerson":"venBio Global Strategic GP, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":4307034,"percentOfClass":3.3,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-004485","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-14","reportingPerson":"venBio Global Strategic GP, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4307034,"percentOfClass":3.3,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-004485","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-14","reportingPerson":"venBio Global Strategic Fund, L.P.","reportingCik":"0001504130","personType":"PN","sharesOwned":4307034,"percentOfClass":3.3,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001193125-26-352359","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Chen Yu","reportingCik":null,"personType":"IN","sharesOwned":5655487,"percentOfClass":4.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001193125-26-352359","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"TCG Crossover GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":2827739,"percentOfClass":2.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001193125-26-352359","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"TCG Crossover Fund II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2827739,"percentOfClass":2.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001193125-26-352359","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"TCG Crossover GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":2827748,"percentOfClass":2.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001193125-26-352359","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"TCG Crossover Fund III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2827748,"percentOfClass":2.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0002012383-26-002155","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":7327850,"percentOfClass":5.4,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001643828-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-27","reportingPerson":"Michael A Carusi","reportingCik":"0001306506","personType":"IN","sharesOwned":2942525,"percentOfClass":2.2,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001643828-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-27","reportingPerson":"Henry A. Plain Jr","reportingCik":"0001384286","personType":"IN","sharesOwned":2942525,"percentOfClass":2.2,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001643828-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-27","reportingPerson":"Jean George","reportingCik":"0001291804","personType":"IN","sharesOwned":2942525,"percentOfClass":2.2,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001643828-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-27","reportingPerson":"LSV Associates, LLC","reportingCik":"0001643828","personType":"OO","sharesOwned":1549132,"percentOfClass":1.2,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001643828-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-27","reportingPerson":"Lightstone Ventures II, L.P.","reportingCik":"0001699565","personType":"PN","sharesOwned":1315255,"percentOfClass":1,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001643828-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-27","reportingPerson":"Lightstone Ventures, L.P.","reportingCik":"0001572522","personType":"PN","sharesOwned":1363262,"percentOfClass":1,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001643828-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-27","reportingPerson":"LSV Associates II, LLC","reportingCik":"0001818388","personType":"OO","sharesOwned":1393393,"percentOfClass":1,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001643828-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-27","reportingPerson":"Lightstone Ventures II (A), L.P.","reportingCik":"0001706610","personType":"PN","sharesOwned":78138,"percentOfClass":0.1,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001643828-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-27","reportingPerson":"Lightstone Ventures (A), L.P.","reportingCik":"0001572523","personType":"PN","sharesOwned":185870,"percentOfClass":0.1,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-26-062566","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Redmile Group, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":9214188,"percentOfClass":6.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-26-062566","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Jeremy C. Green","reportingCik":null,"personType":"HC,IN","sharesOwned":9214188,"percentOfClass":6.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-26-062512","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"HBM Healthcare Investments (Cayman) Ltd.","reportingCik":null,"personType":"CO","sharesOwned":8590692,"percentOfClass":6.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-26-062566","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Redmile Biopharma Investments III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5267838,"percentOfClass":3.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-26-050505","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1988559,"percentOfClass":1.5,"filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-26-050505","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1988559,"percentOfClass":1.5,"filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-26-050505","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":1988559,"percentOfClass":1.5,"filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-26-050505","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":"00166B105","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":730528,"percentOfClass":0.5,"filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001346824-26-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-02","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":13117106,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001346824-26-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-02","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":13117106,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001346824-26-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-02","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":13117106,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001346824-26-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-02","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":13117106,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001193125-26-041306","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-01-30","reportingPerson":"Chen Yu","reportingCik":null,"personType":"IN","sharesOwned":13011849,"percentOfClass":9.9,"filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001193125-26-041306","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-01-30","reportingPerson":"TCG Crossover Fund II, L.P.","reportingCik":null,"personType":"OO","sharesOwned":6505925,"percentOfClass":5,"filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001193125-26-041306","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-01-30","reportingPerson":"TCG Crossover GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":6505924,"percentOfClass":5,"filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001193125-26-041306","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-01-30","reportingPerson":"TCG Crossover Fund III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6505924,"percentOfClass":5,"filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001193125-26-041306","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-01-30","reportingPerson":"TCG Crossover GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":6505925,"percentOfClass":5,"filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-000512","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-02","reportingPerson":"GOODMAN COREY S","reportingCik":"0001278411","personType":"IN","sharesOwned":13163549,"percentOfClass":10,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-000512","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-02","reportingPerson":"Adelman Robert J","reportingCik":"0001329161","personType":"IN","sharesOwned":12984044,"percentOfClass":9.9,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-000512","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-02","reportingPerson":"venBio Global Strategic GP II, Ltd.","reportingCik":"0001729408","personType":"CO","sharesOwned":8453038,"percentOfClass":6.4,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-000512","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-02","reportingPerson":"venBio Global Strategic GP II, L.P.","reportingCik":"0001729409","personType":"PN","sharesOwned":8453038,"percentOfClass":6.4,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-000512","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-02","reportingPerson":"venBio Global Strategic Fund II L.P.","reportingCik":"0001634632","personType":"PN","sharesOwned":8453038,"percentOfClass":6.4,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-000512","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-02","reportingPerson":"venBio Global Strategic GP, Ltd.","reportingCik":"0001770835","personType":"CO","sharesOwned":4431600,"percentOfClass":3.4,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-000512","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-02","reportingPerson":"venBio Global Strategic GP, L.P.","reportingCik":"0001770834","personType":"PN","sharesOwned":4431600,"percentOfClass":3.4,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0000905148-26-000512","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX ONCOLOGY HOLDINGS INC","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-02-02","reportingPerson":"venBio Global Strategic Fund, L.P.","reportingCik":"0001504130","personType":"PN","sharesOwned":4431600,"percentOfClass":3.4,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001214659-25-016679","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001214659-25-016679","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001214659-25-016679","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001214659-25-016679","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001214659-25-016679","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001214659-25-016679","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001214659-25-016686","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001214659-25-016686","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001214659-25-016686","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001214659-25-016686","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001214659-25-016686","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001214659-25-016686","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-25-101541","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-10-17","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":3188196,"percentOfClass":6,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-25-101541","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-10-17","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":3188196,"percentOfClass":6,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-25-101541","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-10-17","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":3188196,"percentOfClass":6,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-25-101541","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-10-17","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":2730504,"percentOfClass":5.1,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-25-097929","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-10-02","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":2707151,"percentOfClass":5.1,"filedAt":"2025-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-25-097929","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-10-02","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":2707151,"percentOfClass":5.1,"filedAt":"2025-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"},{"accessionNo":"0001104659-25-097929","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001810182","issuerName":"ALX Oncology Holdings Inc.","ticker":"ALXO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-10-02","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":2707151,"percentOfClass":5.1,"filedAt":"2025-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/alxo"}],"updatedAt":"2026-11-05T14:37:24.474Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/alxo","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}